AAP 2022 clinical practice guideline revision on hyperbilirubinemia
A clinical practice guideline revision on managing high bilirubin in newborn infants of 35 or more weeks of gestation, published in Pediatrics in 2022. This atlas lists it as a reference only and does not repeat its content.
- Guideline
- In this atlas
Overview
Technical summary
A 2022 Pediatrics article that revises a clinical practice guideline on managing hyperbilirubinemia in newborns of 35 or more weeks of gestation (the printed title is in the source record). Pediatrics 2022; DOI 10.1542/peds.2022-058859; PMID 35927462. Content from the publisher of Pediatrics is identity-only in this atlas because its terms bar use by AI systems, so nothing was read beyond bibliographic metadata and no recommendation, threshold or claim is recorded. The metadata read names the authors as individuals and the journal’s publisher, but not an issuing organisation, so no issuer or authored_by link is recorded.
About this guideline
- Issued by
- Not reported
- Published
- 2022-08-05
- Status
- Not checked for a newer edition
- Scope
- Management of hyperbilirubinemia in newborn infants of 35 or more weeks of gestation (from the title).
Source
- Document
- Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation (identity record only)
- Publisher
- American Academy of Pediatrics (AAP), named as publisher in the Crossref record of Pediatrics
- Edition note
- Pediatrics 150(3), September 2022 issue, online 5 August 2022. Identity only: the guideline text, its abstract and its PubMed abstract were not fetched or read.
Recommendations
No recommendation in this atlas names this guideline yet.
Record details
- Record id
maternal:guideline-aap-2022-hyperbilirubinemia- Content hash
42726fb81dc0df1275b281e713b89d0491c9ef22d185d7924998c5f8a49d3e9f